Learn how diabetes medications could revolutionize stroke prevention and enhance heart and brain health with breakthrough ...

Allurion catapulted Friday after the company said it plans to test its weight-loss technology with an obesity drug.

The Danish pharma giant posted impressive data for amycretin one month after the disappointing readout of CagriSema.

Underrepresentation of women as participants and researchers in CV clinical trials remains a problem, asserts a review ...

Truist Securities, TD Cowen, Citigroup Inc. ( C) and Canaccord Genuity all also rate BSX "buy," while JPMorgan Chase & Co. ( ...

On 'Super Soul Sunday,' the billionaire media mogul brought up the topic of her lifelong struggles with her weight.

A study confirmed that side effects like pancreatitis and kidney damage are possible while taking GLP-1s like Ozempic. Here's ...

On Friday, however, Novo Nordisk announced top-line results in yet another trial. While the results don't initially sound as ...

Oprah Winfrey recently detailed how taking weight loss drugs shifted her longtime mindset about what she described as “thin ...

A novel GLP-1 and amylin receptor agonist featured a safety profile similar to other incretin-based therapies and conferred a ...

An anxious generation turns to functional foods and beverages and alternative medicine, inspiring better-for-you innovation.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.